目的评价盐酸米多君(管通)治疗女性压力性尿失禁的有效性和安全性。

Objective to evaluate the efficacy and tolerability of midodrine (Gutron) in female patients with stress incontinence.

youdao

因这些药物生产企业未递交盐酸米多君上市后再研究所需要确认患者获益的临床证据，因此，FDA提议撤消盐酸米多君的上市许可。

Since the companies have not been able to provide evidence to confirm the drug's benefit, the FDA is pursuing a withdrawal of the product.

youdao

因这些药物生产企业未递交盐酸米多君上市后再研究所需要确认患者获益的临床证据，因此，FDA提议撤消盐酸米多君的上市许可。

Since the companies have not been able to provide evidence to confirm the drug's benefit, the FDA is pursuing a withdrawal of the product.

youdao